Loralyn Mears has joined Gene Logic as vice president for genomics alliances, the company said last week. She comes to Gene Logic from Sun Microsystems, where she established and led the life sciences program. Mears has a PhD in molecular biology.
Jenne Britell has been elected to the board of directors of Quest Diagnostics, bringing the number of board members to 11, the company said on Monday. She is chairman and CEO of Structured Ventures, a consultancy.
Richard Flavell has joined the scientific advisory board of Seattle Genetics, the Bothell, Wash.-based company said last week. He is chairman and professor of immunobiology at the Yale University School of Medicine and a Howard Hughes investigator. Prior to that, he was chief scientific officer of Biogen an has been a scientific advisor to other companies, including Celltech and CuraGen. Flavell holds a PhD in biochemistry from the University of Hull in the UK.
Robert Bohannon has founded his own diagnostics development lab, Environostics, in Durham, NC, GenomeWeb News has learned. Prior to that, he was vice president of technology, R&D at MedTox Diagnostics in Burlington, NC. Bohannon holds a PhD in molecular virology from Baylor College of Medicine and a BA in molecular, cellular, and developmental biology from the University of Colorado at Boulder.
Francis Collins and Patrick Brown have won awards from the American Society of Human Genetics, ASHG said last week. They will receive the awards during the society's annual meeting in Salt Lake City in October.
Collins, director of the National Human Genome Research Institute, will receive the Allan Award medal and a $10,000 check for his lifetime contributions to understanding human genetics and medical implications of human genetics research.
Brown, a Howard Hughes investigator and Stanford University Medical School professor of genetics, will receive the Curt Stern award and a $2,500 check for his work using gene expression microarrays to provide fundamental insights into the genetic mechanisms of cancer and other human disorders, and into the regulation of gene expression.
CombiMatrix this week launched its CustomArray DNA Synthesizer, which the company said will enable researchers to build microarrays in their own facilities. According to a statement from the Mulkiteo, Wash.-based array company, the platform consists of the DNA CustomArray Synthesizer instrument and its CustomArrays. The instrument has been configured to make CombiMatrix's CustomArray 12K, a semiconductor-based array with 12,000 sites integrated onto a standard 1" x 3" slide format.
GE Healthcare is offering 50% off of its Ni Sepharose 6 Fast Flow 25ml containers. See this link.